Kromek Group PLC (GB:KMK)
LSE:KMK
Want to see GB:KMK full AI Analyst Report?
KMK Stock Chart & Stats
8.50 p
-0.29 p(-5.84%)
At close: 4:00 PM EST
8.50 p
-0.29 p(-5.84%)
Day’s Range― - ―
52-Week Range4.70 p - 13.00 p
Previous CloseN/A
Volume321.93K
Average Volume (3M)3.19M
Market Cap
£66.82M
Enterprise Value73.38M
Total Cash (Recent Filing)£1.25M
Total Debt (Recent Filing)£7.81M
Price to Earnings (P/E)3.6
Beta0.95
Next Earnings
Jun 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding655,136,840
10 Day Avg. Volume2,321,691
30 Day Avg. Volume3,192,291
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)0.63
Price to Sales (P/S)1.23
P/FCF Ratio2.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)£30.42M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained top-line expansion (65.8% latest growth) reflects stronger product demand and successful market penetration across security, industrial and medical channels. Durable revenue momentum supports scale economics, repeat OEM orders, and funding for R&D and commercialization over months.
Expanding Operating MarginsMarked margin improvement across gross, EBIT and EBITDA indicates better cost control and pricing power, likely tied to proprietary detector tech. Higher sustainable margins enhance cash generation potential and provide room to reinvest in product development and defense/security programs.
Low Leverage, Strong Equity BaseA conservatively leveraged balance sheet with high equity proportion gives flexibility to fund contracts, absorb revenue lulls, and invest in growth without heavy interest burdens. This solvency strength reduces refinancing risk and supports multi-month strategic execution.
Bears Say
Negative Free Cash Flow GrowthNegative FCF growth signals the company is not consistently converting profits into discretionary cash, which can constrain internal funding for capex, R&D or shareholder returns. Over a multi-month horizon weak FCF may force external financing or slow investment cadence.
Revenue Cyclicality RiskHeavy reliance on government programs, OEM design-ins and repeat production makes demand lumpy and tied to lengthy procurement cycles. Structural exposure to program funding and OEM adoption timelines increases revenue volatility and execution risk over quarters.
No Dividend PolicyThe lack of a dividend means investors depend solely on capital appreciation. In combination with negative FCF growth, this suggests limited capacity or willingness to return cash, potentially reducing appeal to income-focused investors and limiting long-term shareholder yield options.
Kromek Group plc News
KMK FAQ
What was Kromek Group PLC’s price range in the past 12 months?
Kromek Group PLC lowest share price was 4.70 p and its highest was 13.00 p in the past 12 months.
What is Kromek Group PLC’s market cap?
Kromek Group PLC’s market cap is £66.82M.
When is Kromek Group PLC’s upcoming earnings report date?
Kromek Group PLC’s upcoming earnings report date is Jun 25, 2026 which is in 48 days.
How were Kromek Group PLC’s earnings last quarter?
Kromek Group PLC released its earnings results on Jan 20, 2026. The company reported 0.005 p earnings per share for the quarter, beating the consensus estimate of N/A by 0.005 p.
Is Kromek Group PLC overvalued?
According to Wall Street analysts Kromek Group PLC’s price is currently Overvalued.
Does Kromek Group PLC pay dividends?
Kromek Group PLC does not currently pay dividends.
What is Kromek Group PLC’s EPS estimate?
Kromek Group PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kromek Group PLC have?
Kromek Group PLC has 655,136,840 shares outstanding.
What happened to Kromek Group PLC’s price movement after its last earnings report?
Kromek Group PLC reported an EPS of 0.005 p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -9.565%.
Which hedge fund is a major shareholder of Kromek Group PLC?
Currently, no hedge funds are holding shares in GB:KMK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kromek Group plc Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-7.19%
12-Months-Change
Fundamentals
Return on Equity
22.93%
Trailing 12-Months
Asset Growth
-1.64%
Trailing 12-Months
Company Description
Kromek Group PLC
Kromek Group plc (KMK) is a UK-based technology company that specializes in advanced radiation detection solutions. The company operates primarily in the sectors of security, medical imaging, and nuclear instrumentation. Kromek's core products include high-performance detectors and imaging systems that leverage its proprietary technology, particularly in the fields of gamma and X-ray detection. The company focuses on providing critical insights for applications such as airport security screening, medical diagnostics, and monitoring of nuclear facilities.
Technical Analysis
Gooch & Housego
―
Judges Scientific
―
TT Electronics
―
Windar Photonics
―
discoverIE Group plc
―
Options Prices
Currently, No data available
---